In this article

Fusen Pharma (1652): unapproved advances to company 50% owned by Chairman and controlling shareholder

Company announcement, 23-Mar-2020

Organisations

People

Sign up for our free newsletter

Recommend Webb-site to a friend

Copyright & disclaimer, Privacy policy

Back to top